Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Bicycle Therapeutics PLC maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -559.99%, while the net margin is -503.66%. These profitability ratios, combined with a Return on Equity (ROE) of -34.59%, provide a clear picture of how effectively BCYC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, BCYC competes directly with industry leaders such as FENC and ENTA. With a market capitalization of $397.48M, it holds a significant position in the sector. When comparing efficiency, BCYC's gross margin of 100.00% stands against FENC's 94.70% and ENTA's 100.00%. Such benchmarking helps identify whether Bicycle Therapeutics PLC is trading at a premium or discount relative to its financial performance.
